Please assess the completion status of the following clinical trial:

Trial Title: Supra-inguinal Fascia Iliaca Compartment Block on Postoperative Management in Total Hip Arthroplasty by Posterior Approach

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adults patients scheduled to undergo elective surgery of total hip arthroplasty by posterior surgical aboard~Exclusion Criteria:~* Patient refusal~* Allergy to used medications or local infection.~* Pregnancy~* Obesity with body mass index \> 35~* History of chronic pain or fibromyalgia~* Drug (opioids) addiction~* Treatment with corticosteroids for more than 6 months~* Severe kidney or liver diseases~* Mental disorders or serious neurological diseases

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: t

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo group: patients have multimodal analgesia without fascia-iliaca compartment block
- Fascia iliaca block (Type: EXPERIMENTAL): Patients in this arm have multimodal analgesia with supra-inguinal fascia iliaca compartment block before surgery

Based on this trial design, predict the completion outcome and termination type (if applicable).